Human Stem Cells Institute PJS | |
Stock Exchange | Moscow Exchange |
EPS |
RUB0.46 |
Market Cap |
RUB1.09 B |
Shares Outstanding |
- |
Public Float |
- |
Address |
18/1, Olimpiyskiy Avenue Moscow MC 129110 Russian Federation |
Employees | - |
Website | http://www.hsci.ru |
Updated | 07/08/2019 |
Human Stem Cells Institute OJSC engages in the discovery, research, development, and marketing of proprietary products and services in the field of regenerative medicine, medical genetics, bio-insurance, gene therapy, and biopharmaceutics. Its research and development involves gemacell and cryocell; service for personal regeneration of bone and of gum; nucleostim; preventive treatment program for primary immunodeficiency diseases; human artificial chromosome; development of drugs using histone proteins; and development of drugs using a novel technology employing polysialic acid. The company was founded by Isaev Alexandrovich Artur on November 3, 2003 and is headquartered in Moscow, Russia. |